tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Daniil Gataulin, 103 are a BUY (86.55%), 16 are a HOLD (13.45%).
Analyst Daniil Gataulin, currently employed at CHARDAN CAPITAL, carries an average stock price target met ratio of 35.49% that have a potential upside of 59.98% achieved within 198 days.
Daniil Gataulin’s has documented 211 price targets and ratings displayed on 19 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on EYPT, Eyepoint Pharmaceuticals at 18-Aug-2026.
Analyst best performing recommendations are on CRVO (CERVOMED).
The best stock recommendation documented was for CRVO (CERVOMED) at 3/13/2025. The price target of $14 was fulfilled within 8 days with a profit of $8.21 (141.8%) receiving and performance score of 177.25.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 30-Apr-2024
$5
$0.64 (14.68%)
9 months 24 days ago
(17-Nov-2025)
0/5 (0%)
$0.73 (17.10%)
Buy Since 01-Nov-2023
$5.5
$1.14 (26.15%)
$12
10 months 12 days ago
(29-Oct-2025)
1/7 (14.29%)
$1.27 (30.02%)
292
Hold Since 16-Apr-2025
$4
$-0.36 (-8.26%)
$5
10 months 13 days ago
(28-Oct-2025)
1/2 (50%)
$-0.26 (-6.10%)
168
Buy Since 18-Jul-2024
1 years 28 days ago
(13-Aug-2025)
2/3 (66.67%)
$30.52 (321.94%)
1046
Hold Since 19-Mar-2024
$4
$-0.36 (-8.26%)
$5
1 years 3 months 26 days ago
(15-May-2025)
4/6 (66.67%)
$1.95 (95.12%)
205
Which stock is Daniil Gataulin most bullish on?
Which stock is Daniil Gataulin most reserved on?
What Year was the first public recommendation made by Daniil Gataulin?
